Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Are persistent organic pollutants important in the etiology of feline hyperthyroidism? A review.

Jones B, Engdahl JN, Weiss J.

Acta Vet Scand. 2019 Oct 3;61(1):45. doi: 10.1186/s13028-019-0478-9. Review.

2.

Role of baseline 12‑lead ECG in predicting syncope caused by arrhythmia in patients investigated using an implantable loop recorder.

Sandgren E, Rorsman C, Edvardsson N, Engdahl J.

Int J Cardiol Heart Vasc. 2019 Jun 27;24:100386. doi: 10.1016/j.ijcha.2019.100386. eCollection 2019 Sep.

3.

Comprehensive analyses of geographical inequalities in cardiovascular disease incidence and survival: A possible aid to rationalize prevention strategies.

Strömberg U, Holmén A, Engdahl J.

Eur J Prev Cardiol. 2019 Jun 10:2047487319856940. doi: 10.1177/2047487319856940. [Epub ahead of print] No abstract available.

PMID:
31180760
4.

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

Sawhney JP, Kothiwale VA, Bisne V, Durgaprasad R, Jadhav P, Chopda M, Vanajakshamma V, Meena R, Vijayaraghavan G, Chawla K, Allu J, Pieper KS, John Camm A, Kakkar AK; GARFIELD-AF Investigators.

Indian Heart J. 2018 Nov - Dec;70(6):828-835. doi: 10.1016/j.ihj.2018.09.001. Epub 2018 Sep 12.

5.

Electrocardiography Screening for Atrial Fibrillation.

Engdahl J, Svennberg E, Rosenqvist M.

JAMA. 2018 Dec 25;320(24):2598. doi: 10.1001/jama.2018.17764. No abstract available.

PMID:
30575869
6.

Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation.

Sandgren E, Rorsman C, Edvardsson N, Engdahl J.

PLoS One. 2018 Sep 13;13(9):e0203661. doi: 10.1371/journal.pone.0203661. eCollection 2018.

7.

Usefulness of Short-Lasting Episodes of Supraventricular Arrhythmia (Micro-Atrial Fibrillation) as a Risk Factor for Atrial Fibrillation.

Fredriksson T, Frykman V, Friberg L, Al-Khalili F, Engdahl J, Svennberg E.

Am J Cardiol. 2018 Oct 1;122(7):1179-1184. doi: 10.1016/j.amjcard.2018.06.030. Epub 2018 Jul 4.

PMID:
30064858
8.

Is atrial fibrillation a risk factor for in-hospital cardiac arrest?: a Swedish retrospective cohort study.

Ryden A, Engdahl J, Claesson A, Nordberg P, Ringh M, Hollenberg J, Djärv T.

BMJ Open. 2018 Jun 30;8(6):e022092. doi: 10.1136/bmjopen-2018-022092.

9.

A prospective 5-year follow-up after population-based systematic screening for atrial fibrillation.

Engdahl J, Holmén A, Rosenqvist M, Strömberg U.

Europace. 2018 Nov 1;20(FI_3):f306-f311. doi: 10.1093/europace/euy045.

PMID:
29688312
10.

Factors of importance to 30-day survival after in-hospital cardiac arrest in Sweden - A population-based register study of more than 18,000 cases.

Hessulf F, Karlsson T, Lundgren P, Aune S, Strömsöe A, Södersved Källestedt ML, Djärv T, Herlitz J, Engdahl J.

Int J Cardiol. 2018 Mar 15;255:237-242. doi: 10.1016/j.ijcard.2017.12.068. Epub 2017 Dec 24.

PMID:
29289346
11.

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, Ten Berg JM, Steg PG, Hohnloser SH; RE-DUAL PCI Steering Committee and Investigators.

N Engl J Med. 2017 Oct 19;377(16):1513-1524. doi: 10.1056/NEJMoa1708454. Epub 2017 Aug 27.

12.

Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.

Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, Albert CM, Anderson CS, Antoniou S, Benjamin EJ, Boriani G, Brachmann J, Brandes A, Chao TF, Conen D, Engdahl J, Fauchier L, Fitzmaurice DA, Friberg L, Gersh BJ, Gladstone DJ, Glotzer TV, Gwynne K, Hankey GJ, Harbison J, Hillis GS, Hills MT, Kamel H, Kirchhof P, Kowey PR, Krieger D, Lee VWY, Levin LÅ, Lip GYH, Lobban T, Lowres N, Mairesse GH, Martinez C, Neubeck L, Orchard J, Piccini JP, Poppe K, Potpara TS, Puererfellner H, Rienstra M, Sandhu RK, Schnabel RB, Siu CW, Steinhubl S, Svendsen JH, Svennberg E, Themistoclakis S, Tieleman RG, Turakhia MP, Tveit A, Uittenbogaart SB, Van Gelder IC, Verma A, Wachter R, Yan BP; AF-Screen Collaborators.

Circulation. 2017 May 9;135(19):1851-1867. doi: 10.1161/CIRCULATIONAHA.116.026693. Review.

PMID:
28483832
13.

Designing an optimal screening program for unknown atrial fibrillation: a cost-effectiveness analysis.

Aronsson M, Svennberg E, Rosenqvist M, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Levin LÅ.

Europace. 2017 Oct 1;19(10):1650-1656. doi: 10.1093/europace/eux002.

PMID:
28340009
14.

N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.

Svennberg E, Henriksson P, Engdahl J, Hijazi Z, Al-Khalili F, Friberg L, Frykman V.

Heart. 2017 Aug;103(16):1271-1277. doi: 10.1136/heartjnl-2016-310236. Epub 2017 Mar 2.

PMID:
28255099
15.

Defibrillation before EMS arrival in western Sweden.

Claesson A, Herlitz J, Svensson L, Ottosson L, Bergfeldt L, Engdahl J, Ericson C, Sandén P, Axelsson C, Bremer A.

Am J Emerg Med. 2017 Aug;35(8):1043-1048. doi: 10.1016/j.ajem.2017.02.030. Epub 2017 Feb 16.

PMID:
28238537
16.

Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design.

Engdahl J, Svennberg E, Friberg L, Al-Khalili F, Frykman V, Kemp Gudmundsdottir K, Fredriksson T, Rosenqvist M.

Europace. 2017 Feb 1;19(2):297-302. doi: 10.1093/europace/euw319.

PMID:
28011798
17.

Why should we screen for atrial fibrillation?

Svennberg E, Engdahl J.

Heart. 2017 Jan 1;103(1):6-7. doi: 10.1136/heartjnl-2016-310305. Epub 2016 Oct 12. No abstract available.

PMID:
27733534
18.

Drug therapy in cardiac arrest: a review of the literature.

Lundin A, Djärv T, Engdahl J, Hollenberg J, Nordberg P, Ravn-Fischer A, Ringh M, Rysz S, Svensson L, Herlitz J, Lundgren P.

Eur Heart J Cardiovasc Pharmacother. 2016 Jan;2(1):54-75. doi: 10.1093/ehjcvp/pvv047. Epub 2015 Nov 26. Review.

PMID:
27533062
19.

Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study.

Engdahl J, Holmén A, Svennberg E, Friberg L, Frykman-Kull V, Al-Khalili F, Rosenqvist M, Strömberg U.

Int J Cardiol. 2016 Nov 1;222:430-435. doi: 10.1016/j.ijcard.2016.07.198. Epub 2016 Jul 29.

PMID:
27505329
20.

Detection of Atrial Fibrillation with Intermittent Handheld Electrocardiogram in Patients with Ischemic Stroke and Transient Ischemic Attack.

Olsson AS, Engdahl J.

J Stroke Cerebrovasc Dis. 2016 Nov;25(11):2648-2652. doi: 10.1016/j.jstrokecerebrovasdis.2016.07.010. Epub 2016 Aug 1.

PMID:
27492946

Supplemental Content

Loading ...
Support Center